Final rule 2025-11791
Medical Devices; Radiology Devices; Classification of the Cream for X-Ray Attenuation
The Food and Drug Administration (FDA, the Agency, or we) is classifying the cream for x-ray attenuation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the cream for x-ray attenuation's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2025-11791
- Published
- Jun 26, 2025
- Effective
- Jun 26, 2025
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 27236
Docket identifiers
- Docket No. FDA-2025-N-1361
CFR references
- Title 21, part 892